CGA PS-54

CGA PS-54

$20.00

CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases

Published by Publication Date Number of Pages
CGA 02/01/2018 2
PDF FormatPDF FormatMulti-User-AccessMulti-User AccessPrintablePrintableOnline downloadOnline Download
Category:

Description

CGA PS-54 – CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases

The U.S. Food and Drug Administration (FDA) drug registration and listing regulations, Title 21 of the U.S. Code of Federal Regulations (21 CFR) Part 207, do not address the unique properties of designated medical gas mixtures. Certain accommodations as presented in this position are made to conform with FDA?s requirements for electronic registration and listing submissions.

Product Details

Edition:
1st
Published:
02/01/2018
Number of Pages:
2
File Size:
1 file , 180 KB
Note:
This product is unavailable in Russia, Ukraine, Belarus

In Demand Now